Gyeonggi-do, South Korea

Hyeon Youl Lee

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Kolon Life Science, Inc., Kolon Tissuegene, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyeon Youl Lee. Retrieved from https://idiyas.com/inventor/hyeon-youl-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hyeon Youl Lee

Introduction: Hyeon Youl Lee, a prominent inventor based in Gyeonggi-do, South Korea, has made significant strides in the field of cell therapy. With one active patent to his name, Lee's innovative approach addresses the critical need for evaluating the effectiveness of cell therapeutic agents.

Latest Patents: Hyeon Youl Lee holds a patent titled "Method for assessing validity of cell therapy product." This invention provides a comprehensive method for evaluating the effectiveness of a cell therapeutic agent. By utilizing TGF-β and/or TSP-1 expression levels in two distinct populations of transformed and untransformed mammalian cells, the method allows for a definitive assessment of therapeutic efficacy prior to treatment. This innovation not only ensures the selection of effective therapeutic agents but also minimizes the potential for unnecessary procedures and side effects.

Career Highlights: Lee has garnered experience through his tenure at notable companies, including Kolon Life Science, Inc. and Kolon Tissuegene, Inc. His work in these organizations has been pivotal in advancing the understanding and application of cell therapy products.

Collaborations: Throughout his career, Hyeon Youl Lee has collaborated with esteemed colleagues, including Su Jeong Kim and Sang Eun Noh. These professional relationships have contributed to the development and successful implementation of innovative cell therapies.

Conclusion: Hyeon Youl Lee's contributions to the field of cell therapy and his innovative patent highlight the importance of methodical evaluation in therapeutic effectiveness. His work continues to pave the way for advancements in medical science, ensuring that patients receive only the most effective cell therapeutic agents. The impact of his inventions underscores the vital role of inventors in the ongoing pursuit of medical breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…